0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Next Generation Biomanufacturing"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Bioprocess Monitoring - Global Strategic Business Report - Product Thumbnail Image

Bioprocess Monitoring - Global Strategic Business Report

  • Report
  • May 2025
  • 170 Pages
  • Global
From
EUR$5,850USDGBP
From
EUR$4,950USDGBP
From
EUR$4,500USDGBP
  • 8 Results (Page 1 of 1)
Loading Indicator

The Next Generation Biomanufacturing market is a subset of the biotechnology industry that focuses on the development of advanced manufacturing technologies for the production of biopharmaceuticals. This includes the use of cell and gene therapies, as well as the development of novel bioprocessing techniques. These technologies are used to improve the efficiency and cost-effectiveness of biopharmaceutical production, while also reducing the environmental impact of the process. The Next Generation Biomanufacturing market is driven by the increasing demand for biopharmaceuticals, as well as the need to reduce the cost of production. This has led to the development of new technologies such as single-use bioreactors, automated bioprocessing systems, and advanced analytics. These technologies are being used to improve the efficiency and cost-effectiveness of biopharmaceutical production, while also reducing the environmental impact of the process. Some of the companies in the Next Generation Biomanufacturing market include Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Lonza, and Sartorius AG. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more